Keri has a deep reservoir of communications experience in a range of therapeutic areas, including multiple sclerosis, mental health, vaccines and oncology. Keri thrives on problem-solving, providing counsel on complex, ever-changing marketplace dynamics and connecting stakeholders to achieve shared goals. Keri partners with clients to develop and deliver compelling purpose-driven programming and has cultivated an expertise in patient communications and advocacy relations with an emphasis on the power of patient perspectives to educate, motivate and activate audiences.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.